TELMIN 200 MG/G ORAL PASTE
Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Summary of Product characteristics
(SPC)
04-05-2024
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
MEBENDAZOLE
Available from:
Janssen Cilag Ltd.
ATC code:
QP52AC09
Dosage:
200 mg/g
Pharmaceutical form:
Oral Paste
Therapeutic group:
Endoparasiticide
Therapeutic area:
Donkey
Authorization date:
1989-10-01
Summary of Product characteristics
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Telmin 200 mg/g Oral Paste.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each gram contains:
For a full list of excipients see section 6.1.
3 PHARMACEUTICAL FORM
Oral paste
Beige.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Horse and donkey.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
An oral broad spectrum anthelmintic for the treatment of helminthiasis in the horse and donkey. Telmin is effective against
benzimidazole - susceptible strains of the following worms:
ACTIVE SUBSTANCE:
Menbendazole
200.0 mg
EXCIPIENTS:
Methyl Parahydroxybenzoate 1.902 mg
Propyl Parahydroxybenzoate 0.212 mg
Large strongyles:
_Strongylus vulgaris_
_Strongylus edentatus_
_Strongylus equinus_
_Triodontophorus spp._
Small strongyles:
_Cyathostomes_
_Trichostrongylus axei_
Ascarids:
_Parascaris equorum_
Pinworms:
_Oxyuris equi_
_Probstmayria vivipara_
Lungworms:
_Dictyocaulus arnfieldi_
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 02/04/2012_
_CRN 7012020_
_page number: 1_
4.3 CONTRAINDICATIONS
Do not use in animals with known hypersensitivity to the active ingredient.
Do not treat animals during the first 4 months of pregnancy with doses of 15 mg/kg or over.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
For use in donkeys at a higher dose rate, see Section 4.9
Horses which are too thin or prone to colic must be examined by a veterinary surgeon prior to treatment.
Care should be taken to avoid the following practices because they increase the risk of development of resistance and
could ultimately result in ineffective therapy:
Too frequent and repeated use of anthelmintics from the same class, over an extended period of time.
Underdosing, which may be due
Read the complete document
